会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • 5-fluorouracil derivative and its preparation
    • 5-氟尿嘧啶衍生物及其制备
    • JPS58216169A
    • 1983-12-15
    • JP10097182
    • 1982-06-11
    • Tanabe Seiyaku Co Ltd
    • INOUE KAZUMIIWASAKI TAMEONISHITANI TAKASHIKONDOU KAZUHIKOARAI YOSHIHISA
    • C07D239/553A61K31/505A61P35/00C07D239/54
    • NEW MATERIAL:5-Fluorouracil derivative of formula I (R
      1 is H, 1W15C alkyl, lower alkyl substituted with lower alkoxy; R
      2 is formyl, lower alkanoyl, halogen-substituted lower alkanoyl; R
      3 is lower alkyl, lower alkyl substituted with phenyl-lower-alkoxy; R
      4 is lower alkyl, lower alkyl substituted with phenyl- lower-alkoxy) or its salt.
      EXAMPLE: N-Acetyl-N-methyl-2-(5-fluorouracil-1-yl)glycine ethyl ester.
      USE: Since it has antitumor activity, it is used as a medicine.
      PREPARATION: The reaction between 2,4-bis(trimethylsilyl)-5-fluorouracil and a compound of formula II (R
      5 is H, 1W5C alkyl; R
      6 is formyl; R
      7 is lower alkyl; R
      8 is lower alkyl; Z is lower alkanoyloxy) in the presence of a Lewis acid gives the compound of formula I .
      COPYRIGHT: (C)1983,JPO&Japio
    • 新材料:式I的5-氟尿嘧啶衍生物(R 1是H,1-15C烷基,被低级烷氧基取代的低级烷基; R 2是甲酰基,低级烷酰基,卤素取代的低级烷酰基; R 3, 是低级烷基,被苯基 - 低级烷氧基取代的低级烷基; R 4是低级烷基,被苯基 - 低级烷氧基取代的低级烷基)或其盐。 实施例:N-乙酰基-N-甲基-2-(5-氟尿嘧啶-1-基)甘氨酸乙酯。 用途:由于具有抗肿瘤活性,用作药物。 制备:2,4-双(三甲基甲硅烷基)-5-氟尿嘧啶与式II化合物(R 5)之间的反应是H,1-5C烷基; R 6是甲酰基; R 7是低级烷基 ; R 8为低级烷基; Z为低级烷酰氧基),在路易斯酸存在下,得到式I化合物。
    • 2. 发明专利
    • 5-fluorouracil derivative and its preparation
    • 5-氟尿嘧啶衍生物及其制备
    • JPS5927876A
    • 1984-02-14
    • JP13708882
    • 1982-08-05
    • Tanabe Seiyaku Co Ltd
    • MIYOSHI SOUJIINOUE KAZUMIMUSHISHIKA YOSHITAKAIWASAKI TAMEONISHITANI TAKASHIARAI YOSHIHISA
    • C07D239/553A61K31/505A61P35/00
    • NEW MATERIAL:A compound shown by the formula I (R
      1 is lower alkyl, or lower alkenyl; R
      2 is lower alkenyl, substituted lower alkyl, substituted-aralkyl, etc.; R
      3 is H, or lower alkoxycarbonyl) and its pharmaceutically acceptable salts.
      EXAMPLE: N-Methoxyacetyl-2-(5-fluorouracil-1-yl)leucine ethyl ester.
      USE: An antitumor agent.
      PROCESS: A compound shown by the formula III (R
      4 is lower alkenyl, substituted lower alkyl, substituted-aralkyl, etc.; Y is lower alkoxy, or lower alkanoyloxy) is reacted with a compound shown by the formula II in the presence of Lewis acid, or a compound shown by the formula III (Z is lower alkanoyloxy) is reacted with a compound shown by the formula IV in the presence of an alkali metal hybride, to give the desired compound.
      COPYRIGHT: (C)1984,JPO&Japio
    • 新材料:由式I表示的化合物(R 1是低级烷基或低级烯基; R 2是低级链烯基,取代的低级烷基,取代的 - 芳烷基等; R 3是H或 低级烷氧基羰基)及其药学上可接受的盐。 实施例:N-甲氧基乙酰基-2-(5-氟尿嘧啶-1-基)亮氨酸乙酯。 用途:抗肿瘤剂。 方法:式Ⅲ化合物(R 4为低级链烯基,取代的低级烷基,取代的芳烷基等; Y为低级烷氧基或低级烷酰氧基)与式II所示的化合物反应 在碱金属混合物存在下,将路易斯酸或式III化合物(Z为低级烷酰氧基)的存在与式Ⅳ所示的化合物反应得到所需化合物。
    • 3. 发明专利
    • 5-fluorouracil derivative and preparation thereof
    • 5-氟尿嘧啶衍生物及其制备方法
    • JPS58213762A
    • 1983-12-12
    • JP9670982
    • 1982-06-04
    • Tanabe Seiyaku Co Ltd
    • MIYOSHI SOUJIINOUE KAZUMIMUSHISHIKA YOSHITAKAIWASAKI TAMEONISHITANI TAKASHIARAI YOSHIHISA
    • C07D239/553A61K31/505A61P35/00C07D239/54C07D403/06C07D405/06
    • NEW MATERIAL:A compound expressed by formula I (R
      1 is lower alkoxyl, lower alkoxy-substituted lower alkoxyl, lower cycloalkyl, lower cycloalkyloxy, lower alkoxycarbonyl or benzyloxycarbonyl, etc.; R
      2 is H or lower alkyl; R
      3 is lower alkyl; A is lower alkylene) or a salt thereof.
      EXAMPLE: N-Acetyl-2-isopropoxymethyl-2-(5-fluorouracil-1-yl)glycine ethyl ester.
      USE: A medicine having antitumor action.
      PROCESS: A compound expressed by formula II (R
      4 is lower alkoxyl, lower alkoxy-substituted lower alkoxyl, lower cycloalkyl, etc.; R
      5 is lower alkanoyl) is reacted with a 2,4-bistrimethylsilyl-5-fluorouracil expressed by formula III in a solvent in the presence of a Lewis acid to afford the compound expressed by formula I (R
      1 is R
      4 ).
      COPYRIGHT: (C)1983,JPO&Japio
    • 新材料:由式I表示的化合物(R 1)为低级烷氧基,低级烷氧基取代的低级烷氧基,低级环烷基,低级环烷氧基,低级烷氧基羰基或苄氧羰基等; R 2为H或低级烷基; R 3为低级烷基; A为低级亚烷基)或其盐。 实施例:N-乙酰基-2-异丙氧基甲基-2-(5-氟尿嘧啶-1-基)甘氨酸乙酯。 用途:具有抗肿瘤作用的药物。 方法:由式II表示的化合物(R 4是低级烷氧基,低级烷氧基取代的低级烷氧基,低级环烷基等; R 5是低级烷酰基)与2,4-双三甲基甲硅烷基-5- 在路易斯酸存在下,在溶剂中由式III表示的氟尿嘧啶,得到由式I表示的化合物(R 1为R 4)。
    • 4. 发明专利
    • 5-fluorouracil derivative and its preparation
    • 5-氟尿嘧啶衍生物及其制备
    • JPS58222071A
    • 1983-12-23
    • JP10514382
    • 1982-06-17
    • Tanabe Seiyaku Co Ltd
    • MIYOSHI SOUJIINOUE KAZUMIMUSHISHIKA YOSHITAKAIWASAKI TAMEONISHITANI TAKASHIARAI YOSHIHISA
    • C07D239/553A61K31/505A61P35/00C07D239/54
    • NEW MATERIAL:The 5-fluorouracil derivative of formula I [R
      1 and R
      2 are lower alkyl; R
      3 is OR
      4 (R
      4 is alkenyl, alkynyl, etc.) or NR
      5 R
      6 (R
      5 is H or alkyl; R
      6 is alkyl, monoalkoxycarbonyl-substituted alkyl, etc.)] or its pharmacologically permissible salt.
      EXAMPLE: N-Acetyl-2-(5-fluorouracil-1-yl)leucine 2-methoxyethyl ester.
      USE: Antitumor agent.
      PROCESS: The compound of formula I -a which is one of the compound of formula I , can be prepared, e.g. by reacting 2,4-bistrimethylsilyl-5-fluorouracil of formula II with the compound of formula III (R
      7 is alkanoyl; R
      8 is alkoxy- substituted alkyl) in the presence of a Lewis acid, and if desired, converting the product to a pharmacologically permissible salt.
      COPYRIGHT: (C)1983,JPO&Japio
    • 新材料:式Ⅰ的5-氟尿嘧啶衍生物[R 1和R 2]为低级烷基; R 3是OR 4(R 4是烯基,炔基等)或NR 5 R 6(R 5是H或烷基; R 6是烷基,单烷氧基羰基 - 取代的烷基等)]或其药理学上允许的盐。 实施例:N-乙酰基-2-(5-氟尿嘧啶-1-基)亮氨酸2-甲氧基乙酯。 用途:抗肿瘤剂。 方法:可以制备作为式I化合物之一的式I-a化合物,例如 通过在路易斯酸的存在下,使式II的2,4-双三甲基甲硅烷基-5-氟尿嘧啶与式III化合物(R 7是烷酰基; R 8是烷氧基取代的烷基)反应,如果需要, 将产品转化为药理学上允许的盐。